Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel and Radiation in Post-Prostatectomy Prostate Cancer
NCT01650285Phase 2Terminated
- Sponsor
- Brown University
- Start
- Jan 2013
- Primary completion
- Jul 2014
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel in prostate cancer (PCa), sponsored by Brown University. Started Jan 2013; status: terminated.
02
Drugs
cabazitaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01650285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01650285.